| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±1.9% | -0.4% | over-priced |
| October 31, 2025 | ±1.5% | +0.8% | over-priced |
| July 31, 2025 | ±1.4% | -1.4% | under-priced |
| April 30, 2025 | ±2.3% | -0.3% | over-priced |
| October 29, 2024 | ±1.9% | -0.2% | over-priced |
| July 30, 2024 | ±1.6% | +0.5% | over-priced |
| April 30, 2024 | ±1.7% | -1.4% | over-priced |
| October 31, 2023 | ±2.8% | +2.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.11 | $30.3B | $8.6B |
| Q4 FY2025 | $0.96 | $31.2B | $7.5B |
| Q3 FY2025 | $1.06 | $28.1B | $8.5B |
| Q2 FY2025 | $0.89 | $26.5B | $7.1B |
Bank of America Corporation (BAC) reports in 94 days, with the next report estimated for September 15, 2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced BAC's earnings risk. Fundamentals into the print: EPS up 23.3% year-over-year, revenue up 10.6%. QuantLogix's live 5-factor engine currently reads BAC as a buy at 67/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →